Author Correction: Molecular engineering of safe and efficacious oral basal insulin

Correction to: Nature Communications 10.1038/s41467-020-17487-9, published online 27 July 2020.

The original version of this Article omitted the following from the Acknowledgements:

“We are grateful to Janos Tibor Kodra and Jette Lenstrup, both of Novo Nordisk A/S, who conceived and provided the OI216 insulin analogue. Furthermore, we are appreciative of Inger Lautrup-Larsen, Novo Nordisk A/S, contributions with recombinant expressing, as well as many colleagues’ producing, purifying and quantifying the compounds used in this study”.

This has now been corrected in both the PDF and HTML versions of the Article.